Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy

Asian Journal of Pharmaceutical Sciences - Tập 17 - Trang 583-595 - 2022
Yang Sui1, Ji Li2, Jiqiang Qu3, Ting Fang4, Hongyan Zhang5, Jian Zhang1, Zheran Wang6, Mingyu Xia3, Yinghui Dai2, Dongkai Wang1
1Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China
2Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, China
3School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China
4School of Pharmacy, China Medical University, Shenyang 110122, China
5School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
6Department of Mathematics and Statistics, Auburn University, Auburn, AL 36849, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Asian Journal of Pharmaceutical Sciences

Tập 17

583-595

Thông tin tác giả